Methotrexate-plasmid DNA polyplexes for cancer therapy: Characterization, cancer cell targeting ability and tuned in vitro transfection
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Journal of Molecular Liquids
- Vol. 292
Abstract
No abstract availableFunding Information
- Fundação para a Ciência e a Tecnologia
This publication has 37 references indexed in Scilit:
- Mechanisms and Implications of Dual-Acting Methotrexate in Folate-Targeted Nanotherapeutic DeliveryInternational Journal of Molecular Sciences, 2015
- Multifunctional ATRP based pH responsive polymeric nanoparticles for improved doxorubicin chemotherapy in breast cancer by proton sponge effect/endo-lysosomal escapePolymer Chemistry, 2015
- Smart Polymeric Nanoparticles for Cancer Gene DeliveryMolecular Pharmaceutics, 2014
- Using Fourier transform IR spectroscopy to analyze biological materialsNature Protocols, 2014
- Methotrexate conjugated magnetic nanoparticle for targeted drug delivery and thermal therapyJournal of Applied Physics, 2014
- Methotrexate-Loaded PEGylated Chitosan Nanoparticles: Synthesis, Characterization, and in Vitro and in Vivo Antitumoral ActivityMolecular Pharmaceutics, 2013
- The Possible “Proton Sponge ” Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pHMolecular Therapy, 2013
- How Does DNA Complex with Polyethylenimine with Different Chain Lengths and Topologies in Their Aqueous Solution Mixtures?Macromolecules, 2012
- The role of the E6-p53 interaction in the molecular pathogenesis of HPVOncogene, 1999
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993